[1]“DHEA.” 2021. February 12, 2021. https://www.mayoclinic.org/drugs-supplements-dhea/art-20364199.
[2]Garnero, P., E. Sornay-Rendu, B. Claustrat, and P. D. Delmas. 2000. “Biochemical Markers of Bone Turnover, Endogenous Hormones and the Risk of Fractures in Postmenopausal Women: The OFELY Study.” Journal of Bone and Mineral Research: The Official Journal of the American Society for Bone and Mineral Research 15 (8). https://doi.org/10.1359/jbmr.2000.15.8.1526.
[3]Mühlen, D. von, G. A. Laughlin, D. Kritz-Silverstein, J. Bergstrom, and R. Bettencourt. 2008. “Effect of Dehydroepiandrosterone Supplementation on Bone Mineral Density, Bone Markers, and Body Composition in Older Adults: The DAWN Trial.” Osteoporosis International: A Journal Established as Result of Cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 19 (5). https://doi.org/10.1007/s00198-007-0520-z.
[4]Basile, Lisa Marie. n.d. “Hormonal Imbalances and Depression.” Accessed November 24, 2021. https://www.endocrineweb.com/hormonal-imbalances-depression.
[5]Morrison, M. F., E. W. Freeman, H. Lin, and Sammel. 2011. “Higher DHEA-S (dehydroepiandrosterone Sulfate) Levels Are Associated with Depressive Symptoms during the Menopausal Transition: Results from the PENN Ovarian Aging Study.” Archives of Women’s Mental Health 14 (5). https://doi.org/10.1007/s00737-011-0231-5.
[6]Genazzani, A. R., M. Stomati, V. Valentino, N. Pluchino, E. Pot, E. Casarosa, S. Merlini, A. Giannini, and M. Luisi. 2011. “Effect of 1-Year, Low-Dose DHEA Therapy on Climacteric Symptoms and Female Sexuality.” Climacteric: The Journal of the International Menopause Society 14 (6). https://doi.org/10.3109/13697137.2011.579649.
[7] Brooke, A. M., L. A. Kalingag, F. Miraki-Moud, C. Camacho-Hübner, K. T. Maher, D. M. Walker, J. P. Hinson, and J. P. Monson. 2006. “Dehydroepiandrosterone Improves Psychological Well-Being in Male and Female Hypopituitary Patients on Maintenance Growth Hormone Replacement.” The Journal of Clinical Endocrinology and Metabolism 91 (10). https://doi.org/10.1210/jc.2006-0316.
[8]Reiter, W. J., A. Pycha, G. Schatzl, A. Pokorny, D. M. Gruber, J. C. Huber, and M. Marberger. 1999. “Dehydroepiandrosterone in the Treatment of Erectile Dysfunction: A Prospective, Double-Blind, Randomized, Placebo-Controlled Study.” Urology 53 (3). https://doi.org/10.1016/s0090-4295(98)00571-8.
[9]Peixoto, C., C. G. Carrilho, J. A. Barros, T. T. Ribeiro, L. M. Silva, A. E. Nardi, A. Cardoso, and A. B. Veras. 2017. “The Effects of Dehydroepiandrosterone on Sexual Function: A Systematic Review.” Climacteric: The Journal of the International Menopause Society 20 (2). https://doi.org/10.1080/13697137.2017.1279141.
[10]Elraiyah, T., M. B. Sonbol, Z. Wang, T. Khairalseed, N. Asi, C. Undavalli, M. Nabhan, et al. 2014. “Clinical Review: The Benefits and Harms of Systemic Dehydroepiandrosterone (DHEA) in Postmenopausal Women with Normal Adrenal Function: A Systematic Review and Meta-Analysis.” The Journal of Clinical Endocrinology and Metabolism 99 (10). https://doi.org/10.1210/jc.2014-2261.
[11]Wiser, A., O. Gonen, Y. Ghetler, T. Shavit, A. Berkovitz, and A. Shulman. 2010. “Addition of Dehydroepiandrosterone (DHEA) for Poor-Responder Patients before and during IVF Treatment Improves the Pregnancy Rate: A Randomized Prospective Study.” Human Reproduction 25 (10). https://doi.org/10.1093/humrep/deq220.
[12]Barad, D., and N. Gleicher. 2006. “Effect of Dehydroepiandrosterone on Oocyte and Embryo Yields, Embryo Grade and Cell Number in IVF.” Human Reproduction 21 (11). https://doi.org/10.1093/humrep/del254.
[13]Srinivasan, Manivannan, Brian A. Irving, Ketan Dhatariya, Katherine A. Klaus, Stacy J. Hartman, Joseph P. McConnell, and K. Sreekumaran Nair. 2009. “Effect of Dehydroepiandrosterone Replacement on Lipoprotein Profile in Hypoadrenal Women.” The Journal of Clinical Endocrinology and Metabolism 94 (3): 761.
[14]Peixoto, C., Devicari Cheda Jn, A. E. Nardi, A. B. Veras, and A. Cardoso. 2014. “The Effects of Dehydroepiandrosterone (DHEA) in the Treatment of Depression and Depressive Symptoms in Other Psychiatric and Medical Illnesses: A Systematic Review.” Current Drug Targets 15 (9). https://doi.org/10.2174/1389450115666140717111116.
[15]Peixoto, C., C. G. Carrilho, J. A. Barros, T. T. Ribeiro, L. M. Silva, A. E. Nardi, A. Cardoso, and A. B. Veras. 2017. “The Effects of Dehydroepiandrosterone on Sexual Function: A Systematic Review.” Climacteric: The Journal of the International Menopause Society 20 (2). https://doi.org/10.1080/13697137.2017.1279141.
[16]Elraiyah, T., M. B. Sonbol, Z. Wang, T. Khairalseed, N. Asi, C. Undavalli, M. Nabhan, et al. 2014. “Clinical Review: The Benefits and Harms of Systemic Dehydroepiandrosterone (DHEA) in Postmenopausal Women with Normal Adrenal Function: A Systematic Review and Meta-Analysis.” The Journal of Clinical Endocrinology and Metabolism 99 (10). https://doi.org/10.1210/jc.2014-2261.
[17] Igwebuike, A., B. A. Irving, M. L. Bigelow, K. R. Short, J. P. McConnell, and K. S. Nair. 2008. “Lack of Dehydroepiandrosterone Effect on a Combined Endurance and Resistance Exercise Program in Postmenopausal Women.” The Journal of Clinical Endocrinology and Metabolism 93 (2). https://doi.org/10.1210/jc.2007-1027.
[18]Lasco, A., N. Frisina, N. Morabito, A. Gaudio, E. Morini, A. Trifiletti, G. Basile, V. Nicita-Mauro, and D. Cucinotta. 2001. “Metabolic Effects of Dehydroepiandrosterone Replacement Therapy in Postmenopausal Women.” European Journal of Endocrinology / European Federation of Endocrine Societies 145 (4). https://doi.org/10.1530/eje.0.1450457.
[19]Rutkowski, K., P. Sowa, J. Rutkowska-Talipska, A. Kuryliszyn-Moskal, and R. Rutkowski. 2014. “Dehydroepiandrosterone (DHEA): Hypes and Hopes.” Drugs 74 (11). https://doi.org/10.1007/s40265-014-0259-8.
[20]“DHEA.” 2021. February 12, 2021. https://www.mayoclinic.org/drugs-supplements-dhea/art-20364199.
コメント
コメントを追加